Skip to main content
. 2008 Feb 12;19(4):399–428. doi: 10.1007/s00198-008-0560-z

Fig. 6.

Fig. 6

Cost-effectiveness (£000/QALY gained) of treatment in women aged 50–70 years, by the presence or absence of a prior fracture and osteoporosis. (Reprinted from [148], with permission from Elsevier). The solid horizontal line indicates the threshold for cost-effectiveness (£30,000—approximately 43,000 Euros – currency conversion here and elsewhere at October 2007)